Related references
Note: Only part of the references are listed.Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure
Sakurako Suma et al.
INTERNAL MEDICINE (2022)
LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms
Christian Marinaccio et al.
CANCER DISCOVERY (2021)
The orphan nuclear receptor NR4A1 promotes FcεRI-stimulated mast cell activation and anaphylaxis by counteracting the inhibitory LKB1/AMPK axis
Fansi Jin et al.
ALLERGY (2019)
Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management
Animesh Pardanani
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Qingsong Gao et al.
CELL REPORTS (2018)
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
Mohamad Jawhar et al.
HAEMATOLOGICA (2017)
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
Mohamad Jawhar et al.
HAEMATOLOGICA (2017)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis
Celalettin Ustun et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
AMP-activated protein kinase negatively regulates FcεRI-mediated mast cell signaling and anaphylaxis in mice
Seung-Lark Hwang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation
Alexa S. Green et al.
BLOOD (2010)
LKB1; linking cell structure and tumor suppression
A. F. Hezel et al.
ONCOGENE (2008)
A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia - The Japan adult leukemia study group AML97 study
S Miyawaki et al.
CANCER (2005)
Share Paper
